Theravance Biopharma
TBPH
TBPH
90 hedge funds and large institutions have $297M invested in Theravance Biopharma in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $369M → $297M (-$72.1M)
70% less call options, than puts
Call options by funds: $77K | Put options by funds: $261K
Holders
90
Holding in Top 10
1
Calls
$77K
Puts
$261K
Top Buyers
| 1 | +$6.02M | |
| 2 | +$4.68M | |
| 3 | +$3.44M | |
| 4 |
CC
Clearline Capital
New York
|
+$3.18M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.89M |
Top Sellers
| 1 | -$8.18M | |
| 2 | -$3.75M | |
| 3 | -$1.84M | |
| 4 |
First Manhattan
New York
|
-$1.65M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$989K |